BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27293018)

  • 1. Can the phenotype of inherited fibrinogen disorders be predicted?
    Casini A; de Moerloose P
    Haemophilia; 2016 Sep; 22(5):667-75. PubMed ID: 27293018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Bor MV
    Ugeskr Laeger; 2024 Jan; 186(1):. PubMed ID: 38235772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
    Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH.
    Casini A; Undas A; Palla R; Thachil J; de Moerloose P;
    J Thromb Haemost; 2018 Sep; 16(9):1887-1890. PubMed ID: 30076675
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.
    Neerman-Arbez M; Casini A
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia.
    Shapiro SE; Phillips E; Manning RA; Morse CV; Murden SL; Laffan MA; Mumford AD
    Br J Haematol; 2013 Jan; 160(2):220-7. PubMed ID: 23061815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events-RESPONSE.
    Ramanan R; McFadyen JD; Perkins AC; Tran HA
    Br J Haematol; 2024 Jun; 204(6):2504. PubMed ID: 38607668
    [No Abstract]   [Full Text] [Related]  

  • 9. Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events.
    Bor MV
    Br J Haematol; 2024 Jun; 204(6):2501-2503. PubMed ID: 38607667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Casini A; Al-Samkari H; Hayward C; Peyvandi F
    Haemophilia; 2024 Apr; 30 Suppl 3():60-69. PubMed ID: 38494995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen: Structure, abnormalities and laboratory assays.
    Güven B; Can M
    Adv Clin Chem; 2024; 120():117-143. PubMed ID: 38762239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of acquired dysfibrinogenaemia in adult patients with sepsis using fibrinogen function vs. concentration ratios: a cross-sectional study.
    Toenges R; Steiner M; Weber CF; Miesbach W
    Front Med (Lausanne); 2023; 10():1294301. PubMed ID: 38152302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital afibrinogenemia: report of three cases.
    Anwar M; Iqbal H; Gul M; Saeed N; Ayyub M
    J Thromb Haemost; 2005 Feb; 3(2):407-9. PubMed ID: 15670062
    [No Abstract]   [Full Text] [Related]  

  • 14. Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia.
    Colom H; Blasi A; Montoro B; Arévalo AG; Cendrós JM; Sabaté A
    Br J Clin Pharmacol; 2023 Sep; 89(9):2703-2713. PubMed ID: 37041125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools.
    Ramanan R; McFadyen JD; Perkins AC; Tran HA
    Br J Haematol; 2023 Nov; 203(3):355-368. PubMed ID: 37583269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental management of a 4-year-old child with congenital afibrinogenemia-A rare case report.
    Khodke S; Varkey IM; Ghule KD; Naik S; Dsouza A; Thakur K; Mehta S; Valke P
    Spec Care Dentist; 2023; 43(5):708-712. PubMed ID: 36567261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.
    Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27832. PubMed ID: 31131962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen concentrates in hereditary fibrinogen disorders: Past, present and future.
    Casini A; de Moerloose P
    Haemophilia; 2020 Jan; 26(1):25-32. PubMed ID: 31709664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of congenital quantitative fibrinogen disorders: a Delphi consensus.
    Casini A; de Moerloose P;
    Haemophilia; 2016 Nov; 22(6):898-905. PubMed ID: 27640400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report.
    Gu L; Wang B; Liu L; Gan Q; Liu X; Chen L; Chen L
    J Int Med Res; 2020 Jan; 48(1):300060519898033. PubMed ID: 31965886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.